Besides, a study constructed and verified a prognostic risk model of targeting autophagy-related gene (ATG) which contains MMP2-AS1 in NSCLC patients and found that this gene was closely involved in immune modulation in TME. This evidence concerns the gene MMP2 and non-small cell lung carcinoma.